Multiplex PCR for the detection of Mycoplasma fermentans, M-hominis and M-penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome

被引:81
作者
Choppa, PC
Vojdani, A
Tagle, C
Andrin, R
Magtoto, L
机构
[1] Immunosci Lab Inc, Beverly Hills, CA USA
[2] Drew Univ, Sch Med & Sci, Dept Med, Los Angeles, CA USA
关键词
multiplex polymerase chain reaction (PCR); Mycoplasma fermentans; Mycoplasma hominis; Mycoplasma penetrans; chronic fatigue syndrome;
D O I
10.1006/mcpr.1998.0186
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A multiplex polymerase chain reaction (PCR) was initially developed to detect the presence of mycoplasma genus DNA sequences in cell cultures and to differentiate between three human pathogenic mycoplasma species simultaneously. The assay in turn, proved to be a useful tool for the detection of mycoplasma infection in human DNA samples. One set of oligonucleotide primers which are specific for a highly conserved region among all members of the genus mycoplasma along with three other primer sets which are specific for Mycoplasma fermentans, Mycoplasma hominis and Mycoplasma penetrans species were used in this assay. The sensitivity of detection was determined by infecting peripheral blood mononuclear cells (PBMC) of healthy individuals with known bacterial copy numbers from each species, extracting the DNA, and subjecting 1 mu g of DNA from each sample to 40 cycles of amplification. By using agarose gel electrophoresis the detection level was determined to be 7, 7, 9 and 15 mycoplasma cells per mu g of human genomic DNA for M. genus, M. fermentans, M. hominis and M. penetrans, respectively. The assay was applied to DNA extracted from the PBMCs of individuals suffering from chronic fatigue syndrome (CFS) (n=100) as determined by the Center for Dlisease Control (CDC) criteria, and compared to healthy individuals (n=100). The percentage of M. genus infection was found to be 52% in CFS patients and only 15% in healthy individuals. Mycoplasma fermentans, M. hominis and M. penetrans were detected in 32, 9 and 6% of the CFS patients while they were detected in 8, 3 and 2% of the healthy control subjects, respectively. This assay provides a rapid and cost efficient procedure to screen either cell cultures or clinical samples for the presence of three potentially pathogenic species of mycoplasma with a high level of sensitivity and specificity. (C) 1998 Academic Press.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 30 条
[1]   Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety [J].
Baseman, JB ;
Tully, JG .
EMERGING INFECTIOUS DISEASES, 1997, 3 (01) :21-32
[2]   RECOVERY FROM FULMINANT INFECTION WITH MYCOPLASMA-FERMENTANS (INCOGNITUS STRAIN) IN NONIMMUNOCOMPROMISED HOST [J].
BEECHAM, HJ ;
LO, SC ;
LEWIS, DE ;
COMER, SW ;
RILEY, KJ ;
OLDFIELD, EC .
LANCET, 1991, 338 (8773) :1014-1015
[3]   MULTIPLEX PCR AMPLIFICATION AND IMMOBILIZED CAPTURE PROBES FOR DETECTION OF BACTERIAL PATHOGENS AND INDICATORS IN WATER [J].
BEJ, AK ;
MAHBUBANI, MH ;
MILLER, R ;
DICESARE, JL ;
HAFF, L ;
ATLAS, RM .
MOLECULAR AND CELLULAR PROBES, 1990, 4 (05) :353-365
[4]   Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome [J].
Bennett, AL ;
Chao, CC ;
Hu, SX ;
Buchwald, D ;
Fagioli, LR ;
Schur, PH ;
Peterson, PK ;
Komaroff, AL .
JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (02) :160-166
[5]  
Berg S, 1996, MOL CELL PROBE, V10, P7, DOI 10.1006/mcpr.1996.0002
[6]  
Chingbingyong MI, 1996, ARCH ORAL BIOL, V41, P311, DOI 10.1016/0003-9969(96)84556-0
[7]   THE CHRONIC FATIGUE SYNDROME - A COMPREHENSIVE APPROACH TO ITS DEFINITION AND STUDY [J].
FUKUDA, K ;
STRAUS, SE ;
HICKIE, I ;
SHARPE, MC ;
DOBBINS, JG ;
KOMAROFF, A ;
SCHLUEDERBERG, A ;
JONES, JF ;
LLOYD, AR ;
WESSELY, S ;
GANTZ, NM ;
HOLMES, GP ;
BUCHWALD, D ;
ABBEY, S ;
REST, J ;
LEVY, JA ;
JOLSON, H ;
PETERSON, DL ;
VERCOULEN, JHMM ;
TIRELLI, U ;
EVENGARD, B ;
NATELSON, BH ;
STEELE, L ;
REYES, M ;
REEVES, WC .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (12) :953-959
[8]   DEVELOPMENT OF PCR-BASED ASSAYS FOR THE DETECTION OF 2 HUMAN MOLLICUTE SPECIES, MYCOPLASMA-PENETRANS AND M-HOMINIS [J].
GRAU, O ;
KOVACIC, R ;
GRIFFAIS, R ;
LAUNAY, V ;
MONTAGNIER, L .
MOLECULAR AND CELLULAR PROBES, 1994, 8 (02) :139-148
[9]   ASSOCIATION OF MYCOPLASMA AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - DETECTION OF AMPLIFIED MYCOPLASMA-FERMENTANS DNA IN BLOOD [J].
HAWKINS, RE ;
RICKMAN, LS ;
VERMUND, SH ;
CARL, M .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :581-585
[10]   Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos [J].
Hayes, MM ;
Li, BJ ;
Wear, DJ ;
Lo, SC .
INFECTION AND IMMUNITY, 1996, 64 (08) :3419-3424